Fitness
The impact of colistin-based regimens on mortality compared to other antimicrobials in patients with carbapenem-resistant Enterobacterales bacteremia in South African hospitals: a cross-sectional study – BMC Infectious Diseases
Timothy R. Walsh ACGRLPCD. Antimicrobial Resistance: Addressing a Global Threat to Humanity 2023. Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004264.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2017;18(3):318–27.
Goedken CC, Guihan M, Brown CR, Ramanathan S, Vivo A, Suda KJ, et al. Evaluation of carbapenem-resistant Enterobacteriaceae (CRE) guideline implementation in the Veterans Affairs Medical Centers using the consolidated framework for implementation research. Implement Sci Commun. 2021;2(1):69.
Logan LK, Weinstein RA. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis. 2017;215(suppl_1):S28–s36.
Ballot DE, Bandini R, Nana T, Bosman N, Thomas T, Davies VA, et al. A review of-multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg South Africa. BMC Pediatr. 2019;19:1–9.
Mzimela BW, Nkwanyana NM, Singh R. Clinical outcome of neonates with Carbapenem-resistant Enterobacteriaceae infections at the King Edward VIII Hospital’s neonatal unit, Durban, South Africa. Southern Afr J Infect Dis. 2021;36(1):223.
Smith HZ, Kendall B. Carbapenem-Resistant Enterobacteriaceae. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.
Sheu CC, Chang YT, Lin SY, Chen YH, Hsueh PR. Infections caused by carbapenem-resistant enterobacteriaceae: an update on therapeutic options. Front Microbiol. 2019;10:80.
Tilahun M, Kassa Y, Gedefie A, Ashagire M. Emerging carbapenem-resistant enterobacteriaceae infection, its epidemiology and novel treatment options: a review. Infect Drug Resist. 2021;14:4363–74.
Brink AJ, Coetzee J, Richards GA, Feldman C, Lowman W, Tootla HD, et al. Best practices: Appropriate use of the new β-lactam/β-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa. S Afr J Infect Dis. 2022;37(1):453.
Wasan H, Reeta KH, Gupta YK. Strategies to improve antibiotic access and a way forward for lower-middle-income countries. J Antimicrob Chemother. 2023;79(1):1–10.
Otaigbe II, Elikwu CJ. Drivers of inappropriate antibiotic use in low- and middle-income countries. JAC Antimicrob Resist. 2023;5(3):dlad062.
De Maio Carrilho CM, de Oliveira LM, Gaudereto J, Perozin JS, Urbano MR, Camargo CH, et al. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome. BMC Infect Dis. 2016;16(1):629.
Tanise V. Dalmolin DdL-MALB. Plasmid-mediated Colistin Resistance: What Do We Know? 2023 [Available from: https://www.infectiologyjournal.com/articles/plasmidmediated-colistin-resistance-what-do-we-know.pdf.
Grégoire N, Aranzana-Climent V, Magréault S, Marchand S, Couet W. Clinical Pharmacokinetics and Pharmacodynamics of Colistin. Clin Pharmacokinet. 2017;56(12):1441–60.
Moolla MS, Whitelaw A, Decloedt EH, Koegelenberg CFN, Parker A. Opportunities to enhance antibiotic stewardship: colistin use and outcomes in a low-resource setting. JAC Antimicrob Resist. 2021;3(4):dlab169. https://doi.org/10.1093/jacamr/dlab169.
Malande OO, Du Plessis A, Rip D, Bamford C, Eley B. Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: A case series. S Afr Med J. 2016;106(9):877–82.
Majavie L, Johnston D, Messina A. A retrospective review of colistin utilisation at a tertiary care academic hospital in South Africa. S Afr J Infect Dis. 2021;36(1):205.
National Department of Health SOuth Africa. Essential Drugs Programme. Hospital level (Adults) Standard Treatment Guidelines and Essential Medicines List. 5th ed. 2019 2023. Available from: https://www.sapc.za.org/Media/Default/Documents/STG%20hospital%20level%20adult%202019_v2.0.pdf.
Kolman QL, Natalie S, Andries G, Elmien B, Gustav S, Lindie van T, et al. COLISTIN: adult and paediatric guideline for South Africa, 2016. 31. 2019.
Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108–13.
Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis. 2015;2(2):ofv050. https://doi.org/10.1093/ofid/ofv050.
Schmid A, Wolfensberger A, Nemeth J, Schreiber PW, Sax H, Kuster SP. Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis. Sci Rep. 2019;9(1):15290.
Ngoma N, Ismail H, de Voux A, Perovic O. Surveillance for bloodstream infections caused by carbapenem-resistant enterobacterales in South Africa, 2019 and 2020.
Balkan II, Aygün G, Aydın S, Mutcalı SI, Kara Z, Kuşkucu M, et al. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. Int J Infect Dis. 2014;26:51–6.
Schalkwyk OP, Husna I, Erika V. Antimicrobial resistance surveillance in the South African public sector. 33. 2019.
Perovic O, Ismail H, Van Schalkwyk E, Lowman W, Prentice E, Senekal M, Govind CN. Antimicrobial resistance surveillance in the South African private sector report for 2016. Southern Afr J Infect Dis. 2018;33(4):114–7.
Margalit I, Prendki V, Tishler O, Falcone M, Tiseo G, Leibovici-Weissman Y, et al. Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis. J Antimicrob Chemother. 2022;77(8):2094–104.
Kaye KS, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu CH, Daikos G, et al. Colistin monotherapy versus combination therapy for carbapenem-resistant organisms. NEJM Evid. 2023;2(1):10.1056/evidoa2200131. https://doi.org/10.1056/evidoa2200131.
O’Riordan J, Bhally HS, Salmon AH, de Zoysa JR. Successful treatment of carbapenemase producing Enterobacteriaceae peritonitis: “Old therapy for a new bug.” Perit Dial Int. 2020;40(1):100–2.
Hakeam HA, Alsahli H, Albabtain L, Alassaf S, Al Duhailib Z, Althawadi S. Effectiveness of ceftazidime-avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia. Int J Infect Dis. 2021;109:1–7. https://doi.org/10.1016/j.ijid.2021.05.079.
Tumbarello M, Losito AR, Giamarellou H. Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections. Curr Opin Infect Dis. 2018;31(6):566–77.
Ackley R, Roshdy D, Meredith J, Minor S, Anderson WE, Capraro GA, et al. Meropenem-vaborbactam versus ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae infections. Antimicrob Agents Chemother. 2020;64(5):e02313–19. https://doi.org/10.1128/AAC.02313-19.
Trecarichi EM, Tumbarello M. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections. Virulence. 2017;8(4):470–84.
Shields RK, Nguyen MH, Chen L, Press EG, Potoski BA, Marini RV, et al. Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2017;61(8):e00883–17. https://doi.org/10.1128/AAC.00883-17.
From Stadium to Screen: How Technology is Changing Sports Viewing
20/7/2024 Horse Racing Tips and Best Bets – Flemington, Flemington Cup day
Indian tech hub Karnataka state’s move to reserve jobs for locals not finalised, chief minister says
Financial picture dramatically improves for Shamrock Rovers in 48 hours with Sinclair Armstrong deal and European win
Our fashion editor’s favourite affordable bag is 20% off today
Jay Shah’s Big Decision Hovers Over Cricket’s Associate Member Directors Election
Budget shampoo that adds MAJOR volume boost is on sale for Amazon Prime Day: ‘Your hair feels fuller and thicker’
Being active on your commute lowers risk of disease and mental health
Tiger Woods cops brutal Open schedule as full Round 1 tee times revealed
